ClinicalTrials.gg
CompletedNCT03542747Updated Apr 16, 2019

Comparison of iLTS and LMA Fastrach in a Simulated Airway.

An interventional study of Time to ventilation with the iLTS and Time to ventilation with the Fastrach in Ventilation Therapy; Complications, sponsored by Johannes Gutenberg University Mainz. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2019-04-16.

Sponsored by Johannes Gutenberg University Mainz · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Sex
All
01

Study summary

Comparison of time to ventilation based on the chest rising of the Airway Simulator between the iLTS-D and LMA Fastrach

Read the detailed description

Prior to the study every participant obtained a standardized instruction of each device. In the proposed clinical trial the primary study objective will be to determine whether there is a difference in time to ventilation via endotracheal tube (seconds) for the novel iLTS-D compared to the LMA Fastrach. Time to Ventilation will be defined from when the tip of the extraglottic airway device passed the incisors to the point until confirmation the first chest rise of the high fidelity simulator (Laerdal SimMan). Additionally, two time points before final tracheal placement will evaluated: time to place the EGA and time to ventilate with the EGA after introducing the device into the oral cavity.

02

Conditions studied

  • Ventilation Therapy; Complications

Keywords

  • Airway
  • extraglottic
  • simulation
  • laryngeal mask
03

In context

Lead sponsor

Johannes Gutenberg University Mainz is the lead sponsor of 156 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Medical students
  • Present written informed consent of the research participant

Exclusion criteria

Exclusion Criteria:

  • inability to consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Time to ventilation with the iLTS

    Measuring the time to ventilation (ET) based of insert the iLTS until the chest rise of the simulator in seconds

    Device: Time to ventilation with the iLTS · Device: Time to ventilation with the Fastrach

  • Experimental
    Time to ventilation with the Fastrach

    Measuring time to ventilation (ET) based of insert the Fastrach until the chest rise of the simulator in seconds

    Device: Time to ventilation with the iLTS · Device: Time to ventilation with the Fastrach

Interventions

  • DeviceTime to ventilation with the iLTS

    Time to ventilation (ET) based of insert the iLTS until the chest rise of the simulator in seconds

  • DeviceTime to ventilation with the Fastrach

    Time to ventilation (ET) based of insert the Fastrach until the chest rise of the simulator in seconds

06

What researchers measure

Primary outcomes

  1. Time to ventilation via endotracheal tube

    time to ventilation will defined from when the Endotracheal tube insert into the extraglottic airway device until the first chest rise

    Time frame: 0 to 300 seconds

Secondary outcomes

  1. Time to ventilation via extraglottic airway device

    time to ventilation will defined from when the device tip passed the incisors to the point until the first chest rise

    Time frame: 0 to 300 seconds

  2. Intubation attempts

    Numbers of successful intubation attempts (1-5 attempts)

    Time frame: 0 to 300 seconds

  3. Ease of Insertion

    Subjective Grading of the insertion process (Lickert Scale from 1 very easy to 5 very difficult)

    Time frame: 0 to 420 seconds

07

Study locations

1 site
  • Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University
    Mainz, Rhineland-Palatinate D55131, Germany
08

References and documents

Publications

  • Perkins GD, Olasveengen TM, Maconochie I, Soar J, Wyllie J, Greif R, Lockey A, Semeraro F, Van de Voorde P, Lott C, Monsieurs KG, Nolan JP; European Resuscitation Council. European Resuscitation Council Guidelines for Resuscitation: 2017 update. Resuscitation. 2018 Feb;123:43-50. doi: 10.1016/j.resuscitation.2017.12.007. Epub 2017 Dec 9. No abstract available. PubMed 29233740 ↗
  • Ott T, Fischer M, Limbach T, Schmidtmann I, Piepho T, Noppens RR. The novel intubating laryngeal tube (iLTS-D) is comparable to the intubating laryngeal mask (Fastrach) - a prospective randomised manikin study. Scand J Trauma Resusc Emerg Med. 2015 Jun 8;23:44. doi: 10.1186/s13049-015-0126-y. PubMed 26051498 ↗
  • Ott T, Tschope K, Toenges G, Buggenhagen H, Engelhard K, Kriege M. Does the revised intubating laryngeal tube (ILTS-D2) perform better than the intubating laryngeal mask (Fastrach)? - a randomised simulation research study. BMC Anesthesiol. 2020 May 11;20(1):111. doi: 10.1186/s12871-020-01029-3. PubMed 32393169 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2018 to primary completion in Sep 2018, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2018
First posted
May 31, 2018
StartActual
Jun 1, 2018
Primary completionActual
Sep 28, 2018
CompletionActual
Dec 28, 2018
Last update
Apr 16, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03542747
Responsible party
Marc Kriege, MD (MD, Johannes Gutenberg University Mainz) — Principal investigator
First posted
May 31, 2018
Start date
Jun 1, 2018
Primary completion
Sep 28, 2018
Completion
Dec 28, 2018
Last update
Apr 16, 2019

Study contacts

Thomas Ott, MD
study director · Johannes GU, Mainz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion